Global Chronic Idiopathic Constipation Treatment Market Report By Type (Normal-transit constipation,Slow-transit constipation,Others), By Therapy Type (Pharmacological Therapy,Non-pharmacological Therapy), By Treatment Type (Medication (Prescription Drugs, Over the Counter Drugs),Surgery (Laparoscopic Rectopexy, Lateral internal sphincterotomy),Dietary Fiber), By Drugs (Serotonin-4 (5-Ht4) Receptor Agonist,Guanylate Cyclase-C Agonist,Laxatives,Stimulants,Others), By Route of Administration (Oral,Injectable), By End Users (Hospitals,Homecare,Specialty Clinics,Others), By Distribution Channel (Hospital Pharmacies,Retail Pharmacies,Others) And By Regions - Industry Trends, Size, Share, Growth, Estimation and Forecast, 2021-2028

Name: Global Chronic Idiopathic Constipation Treatment Market Report
Brand: Value Market Research
SKU: Healthcare
Price: 3950.00 USD
Availability: OnlineOnly
Rating: 4.2 (80 reviews)

ID:VMR11214173

December 2022

Report Formats: Electronic (PDF), MS EXCEL

Description
Table Of Content

The global demand for Chronic Idiopathic Constipation Treatment Market is presumed to reach the market size of nearly USD XX MN by 2028 from USD XX MN in 2021 with a CAGR of XX% under the study period 2022 - 2028.

Chronic idiopathic constipation (CIC) treatment is used to treat functional lower gastrointestinal disorders called the CIC. CIC is not the same as irritable bowel syndrome (IBS). CIC is characterized by laborious, infrequent, and incomplete defecation and the cause is generally unknown. Various CIC treatment options are available to choose from, like increasing dietary fiber intake, medications like laxatives or biofeedback. There are three subtypes of CIC diagnosed so far. The treatment method selection depends primarily on the cost, tolerability, safety, patient preference, lifestyle considerations, and other pertinent clinical information. CIC can occur in people of all ages.

Market Dynamics

The growing cases of gastrointestinal disorders among the global population will be the main driving force behind this market's growth. The increasing geriatric population, changing dietary habits, and sedentary lifestyles are the leading causes of CIC that will further propel market growth. The heavy investments made towards developing novel therapeutic drugs and emerging treatment methods for CIC will be a market booster. The advancements in drug delivery, high disposable income, and favorable reimbursement policies will augment the market growth. Increasing expenditure on the healthcare sector worldwide will favor market growth. The major hindrance to this market's development is the lack of awareness about the various diagnosis and treatment options available to control CIC.

The research report covers Porter’s Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry’s structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of chronic idiopathic constipation treatment. The growth and trends of chronic idiopathic constipation treatment industry provide a holistic approach to this study.

Market Segmentation

This section of the chronic idiopathic constipation treatment market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.

By Type

Normal-transit Constipation
Slow-transit Constipation
Others

By Therapy Type

Pharmacological Therapy
Non-pharmacological Therapy

By Treatment Type

Medication (Prescription Drugs, Over the Counter Drugs)
Surgery (Laparoscopic Rectopexy, Lateral internal sphincterotomy)
Dietary Fiber

By Drugs

Serotonin-4 (5-Ht4) Receptor Agonist
Guanylate Cyclase-C Agonist
Laxatives
Stimulants
Others

By Route of Administration

Oral
Injectable

By End Users

Hospitals
Homecare
Specialty Clinics
Others

By Distribution Channel

Hospital Pharmacies
Retail Pharmacies
Others

Regional Analysis

This section covers the regional outlook, which accentuates current and future demand for the Chronic Idiopathic Constipation Treatment market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.

Global Chronic Idiopathic Constipation Treatment Market Share by Region (Representative Graph)

The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the chronic idiopathic constipation treatment market include GlaxoSmithKline Plc., Bayer AG, Allergan Plc., Ironwood Pharmaceuticals, Inc., Astellas Pharma, Inc., Synergy Pharmaceuticals, Inc., Sanofi S.A., and Pfizer, Inc.This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.

In case you have any custom requirements, do write to us. Our research team can offer a customized report as per your need.

1 . PREFACE
       1.1. Report Description
           1.1.1. Objective
           1.1.2. Target Audience
           1.1.3. Unique Selling Proposition (USP) & offerings
       1.2. Research Scope
       1.3. Research Methodology
           1.3.1. Market Research Process
           1.3.2. Market Research Methodology

2 . EXECUTIVE SUMMARY
       2.1. Highlights of Market
       2.2. Global Market Snapshot

3 . CHRONIC IDIOPATHIC CONSTIPATION TREATMENT – INDUSTRY ANALYSIS
       3.1. Introduction - Market Dynamics
       3.2. Market Drivers
       3.3. Market Restraints
       3.4. Opportunities
       3.5. Industry Trends
       3.6. Porter’s Five Force Analysis
       3.7. Market Attractiveness Analysis
           3.7.1 By Type
           3.7.2 By Therapy Type
           3.7.3 By Treatment Type
           3.7.4 By Drugs
           3.7.5 By Route of Administration
           3.7.6 By End Users
           3.7.7 By Distribution Channel
           3.7.8 By Region

4 . VALUE CHAIN ANALYSIS
       4.1. Value Chain Analysis
       4.2. Raw Material Analysis
           4.2.1. List of Raw Materials
           4.2.2. Raw Material Manufactures List
           4.2.3. Price Trend of Key Raw Materials
       4.3. List of Potential Buyers
       4.4. Marketing Channel
           4.4.1. Direct Marketing
           4.4.2. Indirect Marketing
           4.4.3. Marketing Channel Development Trend

5 . IMPACT ANALYSIS OF COVID-19 OUTBREAK
       5.1. Impact Analysis of Covid-19 Outbreak
           5.1.1. Direct Impact on Production
           5.1.2. Supply Chain and Market Disruption
           5.1.3. Financial Impact on Firms and Financial Markets
       5.2. COVID-19 Impact Analysis by Production, Import, Export and Demand
       5.3. Market: Pre V/S Post COVID-19
       5.4. Estimated Impact of the Coronavirus (COVID-19) Epidemic
       5.5. COVID-19: Micro and Macro Factor Analysis

6 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY TYPE
       6.1 Overview by Type
       6.2 Historical and Forecast Data
       6.3 Analysis by Type
       6.4 Normal-transit Constipation Market by Regions
       6.5 Slow-transit Constipation Market by Regions
       6.6 Others Market by Regions

7 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY THERAPY TYPE
       7.1 Overview by Therapy Type
       7.2 Historical and Forecast Data
       7.3 Analysis by Therapy Type
       7.4 Pharmacological Therapy Market by Regions
       7.5 Non-pharmacological Therapy Market by Regions

8 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY TREATMENT TYPE
       8.1 Overview by Treatment Type
       8.2 Historical and Forecast Data
       8.3 Analysis by Treatment Type
       8.4 Medication (Prescription Drugs, Over the Counter Drugs) Market by Regions
       8.5 Surgery (Laparoscopic Rectopexy, Lateral internal sphincterotomy) Market by Regions
       8.6 Dietary Fiber Market by Regions

9 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY DRUGS
       9.1 Overview by Drugs
       9.2 Historical and Forecast Data
       9.3 Analysis by Drugs
       9.4 Serotonin-4 (5-Ht4) Receptor Agonist Market by Regions
       9.5 Guanylate Cyclase-C Agonist Market by Regions
       9.6 Laxatives Market by Regions
       9.7 Stimulants Market by Regions
       9.8 Others Market by Regions

10 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY ROUTE OF ADMINISTRATION
       10.1 Overview by Route of Administration
       10.2 Historical and Forecast Data
       10.3 Analysis by Route of Administration
       10.4 Oral Market by Regions
       10.5 Injectable Market by Regions

11 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY END USERS
       11.1 Overview by End Users
       11.2 Historical and Forecast Data
       11.3 Analysis by End Users
       11.4 Hospitals Market by Regions
       11.5 Homecare Market by Regions
       11.6 Specialty Clinics Market by Regions
       11.7 Others Market by Regions

12 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY DISTRIBUTION CHANNEL
       12.1 Overview by Distribution Channel
       12.2 Historical and Forecast Data
       12.3 Analysis by Distribution Channel
       12.4 Hospital Pharmacies Market by Regions
       12.5 Retail Pharmacies Market by Regions
       12.6 Others Market by Regions

13 . GLOBAL CHRONIC IDIOPATHIC CONSTIPATION TREATMENT MARKET ANALYSIS BY GEOGRAPHY
       13.1. Regional Outlook
       13.2. Introduction
       13.3. North America
           13.3.1. Overview, Historic and Forecast Data
           13.3.2. North America By Segment
           13.3.3. North America By Country
           13.3.4. United State
           13.3.5. Canada
           13.3.6. Mexico
       13.4. Europe
           13.4.1. Overview, Historic and Forecast Data
           13.4.2. Europe by Segment
           13.4.3. Europe by Country
           13.4.4. United Kingdom
           13.4.5. France
           13.4.6. Germany
           13.4.7. Italy
           13.4.8. Russia
           13.4.9. Rest Of Europe
       13.5. Asia Pacific
           13.5.1. Overview, Historic and Forecast Data
           13.5.2. Asia Pacific by Segment
           13.5.3. Asia Pacific by Country
           13.5.4. China
           13.5.5. India
           13.5.6. Japan
           13.5.7. South Korea
           13.5.8. Australia
           13.5.9. Rest Of Asia Pacific
       13.6. Latin America
           13.6.1. Overview, Historic and Forecast Data
           13.6.2. Latin America by Segment
           13.6.3. Latin America by Country
           13.6.4. Brazil
           13.6.5. Argentina
           13.6.6. Peru
           13.6.7. Chile
           13.6.8. Rest of Latin America
       13.7. Middle East & Africa
           13.7.1. Overview, Historic and Forecast Data
           13.7.2. Middle East & Africa by Segment
           13.7.3. Middle East & Africa by Country
           13.7.4. Saudi Arabia
           13.7.5. UAE
           13.7.6. Israel
           13.7.7. South Africa
           13.7.8. Rest Of Middle East And Africa

14 . COMPETITIVE LANDSCAPE OF THE CHRONIC IDIOPATHIC CONSTIPATION TREATMENT COMPANIES
       14.1. Chronic Idiopathic Constipation Treatment Market Competition
       14.2. Partnership/Collaboration/Agreement
       14.3. Merger And Acquisitions
       14.4. New Product Launch
       14.5. Other Developments

15 . COMPANY PROFILES OF CHRONIC IDIOPATHIC CONSTIPATION TREATMENT INDUSTRY
       15.1. Company Share Analysis
       15.2. Market Concentration Rate
       15.3. GlaxoSmithKline Plc.
           15.3.1. Company Overview
           15.3.2. Financials
           15.3.3. Products
           15.3.4. Recent Developments
       15.4. Bayer AG
           15.4.1. Company Overview
           15.4.2. Financials
           15.4.3. Products
           15.4.4. Recent Developments
       15.5. Allergan Plc.
           15.5.1. Company Overview
         15.5.2. Financials
           15.5.3. Products
           15.5.4. Recent Developments
       15.6. Ironwood Pharmaceuticals, Inc.
           15.6.1. Company Overview
           15.6.2. Financials
           15.6.3. Products
           15.6.4. Recent Developments
       15.7. Astellas Pharma, Inc.
           15.7.1. Company Overview
           15.7.2. Financials
           15.7.3. Products
           15.7.4. Recent Developments
       15.8. Synergy Pharmaceuticals, Inc.
           15.8.1. Company Overview
           15.8.2. Financials
           15.8.3. Products
           15.8.4. Recent Developments
       15.9. Sanofi S.A.
           15.9.1. Company Overview
           15.9.2. Financials
           15.9.3. Products
           15.9.4. Recent Developments
       15.10. Pfizer, Inc.
           15.10.1. Company Overview
           15.10.2. Financials
           15.10.3. Products
           15.10.4. Recent Developments

*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies

LIST OF TABLES

LIST OF FIGURES

* Kindly note that the above listed are the basic tables and figures of the report and are not limited to the TOC.

Choose your Buying Option

Single User License: $ 3950.00

Upto 10 Users License: $ 4950.00

Enterprise License: $ 8600.00

Data Pack: $ 2100.00

Buy Now

Buy Chapters or Sections

Avail customized purchase options to meet your exact research needs:

Buy sections of this report
Buy country level reports
Request for historical data
Request discounts available for Start-Ups & Universities

Request for Special Pricing

Objectives of Study

Define and measure the global market
Volume or revenue forecast of the global market and its various sub-segments with respect to main geographies
Analyze and identify major market trends along with the factors driving or inhibiting the market growth
Study the company profiles of the major market players with their market share
Analyze competitive developments

Why Choose Us

Client First Policy

Excellent Quality

After Sales Support

24/7 Email Support

Clients

Testimonials

" Doing business with Value Market Research was – quick, easy and accurate. We got what we expected. The team was very helpful and processes were altered for our convenience. The whole process from understanding our niche requirements to delivery to after sales was excellent. "

Vincenzo Baydar – Head Planning, Leading Food Chain, US

" Excellent work!! Working with you has been easy and direct. Your flexibility to alter the report scope and timely delivery assisted me in delivering my project proposal on time. "

Mia Tang, Director - Business Strategy, Steel Industry, Germany

" This is our second purchase and we have been obliged by the service. We appreciate the efforts put by Value Market Research in terms of understanding our needs, expanding the scope of the study, delivery and handling after sales queries. "